| Patents for C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541) | 
|---|
| 11/17/2011 | WO2011141932A2 Process for preparation of phenolic monoesters of hydroxymethyl phenols | 
| 11/17/2011 | WO2011087809A3 2,4,5-triaminophenols and related compounds | 
| 11/17/2011 | US20110282094 Process for preparation of phenolic monoesters of hydroxymethyl phenols | 
| 11/17/2011 | US20110281952 Deuterium-enriched tolterodine | 
| 11/16/2011 | CN102241596A O-aminoalcohol compounds, preparation method thereof and application thereof | 
| 11/16/2011 | CN102241569A Long-acting tackifying phenolic resin and preparation method thereof | 
| 11/16/2011 | CN102240816A Method for preparing nano nickel by taking nano spherical polyelectrolyte brush as reactor and application of nano nickel | 
| 11/16/2011 | CN101693201B Mesopore carbon load nickel hydrogenation catalyst and preparation method thereof | 
| 11/16/2011 | CN101486658B Preparation of 3-(N-ethyl-N-isoamyl) amino phenol | 
| 11/16/2011 | CN101445460B Method for preparing 2-fluoride-5-alkoxyl aniline | 
| 11/15/2011 | CA2685440C Process for producing benzoxazine derivative and production intermediate thereof | 
| 11/15/2011 | CA2435067C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators | 
| 11/10/2011 | WO2011084789A3 Integrated processes for the preparation of polybenzimidazole precursors | 
| 11/10/2011 | WO2011009634A3 Process for producing fingolimod salts | 
| 11/09/2011 | EP2193115B1 Compound, diagnostic agent, nuclear magnetic resonance analysis method, nuclear magnetic resonance imaging method, mass spectrometry method and mass spectrometry imaging method | 
| 11/09/2011 | CN102239134A Methods for making ethanolamine(s) and ethyleneamine(s) from ethylene oxide and ammonia, and related methods | 
| 11/09/2011 | CN102234931A Production process for quaternary ammonium salt softening agent for fabric | 
| 11/09/2011 | CN102234237A Method for preparing L-phenylephrine hydrochloride | 
| 11/03/2011 | WO2011134724A2 Method for preparing ritodrine hydrochloride | 
| 11/03/2011 | US20110269808 Compositions comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases | 
| 11/03/2011 | US20110269709 Prodrugs containing novel bio-cleavable linkers | 
| 11/02/2011 | EP2382172A1 Process for the preparation of optically active compounds using transfer hydrogenation | 
| 11/02/2011 | EP2013183B1 Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the beta2 adrenergic receptor | 
| 11/02/2011 | CN102229536A Method for separating amino alkyl alcohol through membrane electrodialysis | 
| 11/01/2011 | CA2439269C Pharmaceutical salts of 1-phenyl-3-dimethylaminopropane compounds | 
| 10/27/2011 | WO2011133893A2 Cyanide antidotes | 
| 10/27/2011 | WO2011131027A1 Preparation methods of l-phenylephrine hydrochloride | 
| 10/27/2011 | WO2011084765A3 Process for the synthesis of choline salts | 
| 10/27/2011 | US20110263699 1-Phenyl-2-DimethylaminomethylCyclohexane Compounds and Therapies for Depressive Symptoms, Pain and Incontinence | 
| 10/26/2011 | EP2379488A1 Method for producing pure triethanolamine (teoa) | 
| 10/25/2011 | US8044090 N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor | 
| 10/20/2011 | US20110257433 Liquids | 
| 10/20/2011 | US20110257386 Isolation of nucleic acid | 
| 10/20/2011 | US20110257374 Novel Reagents for Directed Biomarker Signal Amplification | 
| 10/20/2011 | CA2793948A1 Novel process for preparing highly pure tapentadol or a pharmaceutically acceptable salt thereof | 
| 10/19/2011 | EP2376425A2 Kinase inhibitor compounds | 
| 10/18/2011 | US8039673 Macromolecular antioxidants comprising differing antioxidant moieties: structures, methods of making and using the same | 
| 10/13/2011 | WO2011125919A1 Novel triarylamines and use thereof | 
| 10/13/2011 | WO2011124927A1 Method of analysing a cell or other biological material containing a nucleic acid | 
| 10/13/2011 | US20110251294 Fast recovery of thixotropy by organogels with low molecular weight gelators | 
| 10/13/2011 | US20110251289 New compounds for the treatment of cancer | 
| 10/13/2011 | US20110251287 Hci polymorphs of 3-((2-(dimethylamino)methyl (cyclohex-1-yl))phenol | 
| 10/13/2011 | US20110251286 Crystalline salts and/or co-crystals of O-desmethyltramadol | 
| 10/13/2011 | US20110251198 Methods for producing viloxazine salts and novel polymorphs thereof | 
| 10/13/2011 | US20110251165 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor | 
| 10/13/2011 | US20110251114 Method for producing mannich adducts that contain polyisobutylene phenol | 
| 10/12/2011 | EP1791805B1 Method for producing triethanolamine | 
| 10/12/2011 | CN102216251A Method for producing optically active cyclopropane carboxylic acid ester compound, asymmetric copper complex, and optically active salicylideneaminoalcohol compound | 
| 10/12/2011 | CN102212562A Method for pre-treating biomass by coupling vapor phase digestion and flash evaporation | 
| 10/12/2011 | CN102212014A Crystal form of O-demethyl-venlafaxine glutamate, preparation method and medicinal application thereof | 
| 10/12/2011 | CN102210663A Diarylalkanes as potent inhibitors of binuclear enzymes | 
| 10/11/2011 | US8034977 Lipids for transfection of nucleic acids | 
| 10/11/2011 | US8034820 Pharmaceutical composition | 
| 10/11/2011 | CA2530790C 2-(amino or substituted amino)-5-(substituted oxymethyl)-phenol compounds, dyeing compositions containing them, and use thereof | 
| 10/11/2011 | CA2453978C Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors | 
| 10/11/2011 | CA2400482C Bupropion metabolites and methods of their synthesis and use | 
| 10/06/2011 | WO2011084762A3 2,4,5-triaminophenols and related compounds | 
| 10/06/2011 | US20110245509 Polyfunctional polyoxyalkylene compound, and producing method and intermediate thereof | 
| 10/06/2011 | US20110243865 Melanin production inhibitor | 
| 10/06/2011 | CA2795023A1 Crystal forms of o-desmethylvenlafaxine fumarate | 
| 10/05/2011 | EP1230209B3 Stable salts of novel derivatives of 3,3-diphenylpropylamines | 
| 10/05/2011 | CN102209705A Crystalline forms of fingolimod hcl | 
| 10/05/2011 | CN102206163A Separation and preparation method for long-chain base | 
| 10/04/2011 | CA2631854C Photochromic indeno-fused naphthopyrans | 
| 10/04/2011 | CA2394117C Process for the preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties | 
| 09/29/2011 | US20110237680 Crystal forms of o-desmethylvenlafaxine fumarate | 
| 09/28/2011 | EP2368871A1 Process for the preperation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol | 
| 09/28/2011 | EP2231586B1 Azomethine direct dyes or reduced precursors of azomethine direct dyes obtained from 2-alkylresorcinols, and hair dyeing process using these dyes or precursors | 
| 09/28/2011 | EP1954668B1 Homo- and heterocyclic compounds suitable as cetp inhibitors | 
| 09/28/2011 | CN102203054A Method for producing n,n-substituted-3-aminopropan-1-ols | 
| 09/28/2011 | CN102199097A Method for preparing 3-(N-ethyl-N-isoamyl) aminophenol | 
| 09/28/2011 | CN102198929A Hollow silicon dioxide sub-microsphere with nanoscale precious metal and silicon dioxide kernel and preparation method thereof | 
| 09/27/2011 | CA2630227C Heterocyclic cetp inhibitors | 
| 09/27/2011 | CA2491472C Process for the preparation of n-monosubstituted .beta.-amino alcohols | 
| 09/22/2011 | WO2011115803A1 Process for making aminoalcohol compounds | 
| 09/22/2011 | WO2011113926A1 Method for preparing tin alkoxides | 
| 09/22/2011 | WO2011092719A3 Process for preparing 1 -phenyl-3 -dimethylaminopropane derivatives | 
| 09/22/2011 | US20110229565 Drug Delivery Composition Comprising a Self-Assembled Gelator | 
| 09/22/2011 | US20110229501 Organic compounds | 
| 09/22/2011 | DE102010012237A1 Direktsynthese von Zinn(II)- und Zinn(IV)-Alkoxiden aus elementarem Zinn und Alkoholen Direct synthesis of tin (II) - and tin (IV) alkoxides of elemental tin and alcohols | 
| 09/21/2011 | CN1880294B Polymorphic forms of dexketoprofen trometamol, preparation and pharmaceutical compositions thereof | 
| 09/21/2011 | CN1697651B 1-phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence | 
| 09/21/2011 | CN102190683A Phosphorous anion ionic liquid and preparation method thereof | 
| 09/21/2011 | CN101774978B Preparation method of linezolid and intermediate thereof | 
| 09/20/2011 | US8022252 Spatially-defined macrocyclic compounds useful for drug discovery | 
| 09/20/2011 | CA2657106C Aminoindane derivative or salt thereof | 
| 09/20/2011 | CA2115828C Calcium receptor active molecules | 
| 09/15/2011 | WO2011110595A1 Crystalline salts and/or cocrystals of o-desmethyltramadol | 
| 09/15/2011 | WO2011110556A1 Short synthesis of tolterodine, intermediates and metabolites | 
| 09/15/2011 | WO2011060332A3 Compositions and methods for treating hyperproliferative disorders | 
| 09/14/2011 | EP2364966A1 Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-3-phenylpropylamines, intermediates for making hydroxytolterodine | 
| 09/14/2011 | EP2364088A1 Bicyclic aryl sphingosine 1-phosphate analogs | 
| 09/14/2011 | CN102186845A S1p receptors modulators and their use thereof | 
| 09/14/2011 | CN102180803A Solvent-free synthesis method of dodecyl bis(2-hydroxyethyl)methylammonium bromide | 
| 09/14/2011 | CN102180800A Synthesis method of aniline compound | 
| 09/13/2011 | US8017807 Tetrahydroxy compound, method for preparing the tetrahydroxy compound, and photoreceptor using the tetrahydroxy compound | 
| 09/13/2011 | US8017655 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents | 
| 09/13/2011 | US8016898 Method for producing Mannich adducts that contain polyisobutylene phenol | 
| 09/13/2011 | CA2486869C Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease | 
| 09/09/2011 | WO2011107876A2 Improved resolution methods for isolating desired enantiomers of tapentadol intermediates and use thereof for the preparation of tapentadol |